Discuss This Disease

4 free views remaining today

spermatogenic failure 62

Description

Spermatogenic failure, also known as non-obstructive azoospermia, is a condition where there is a disruption in the production of spermatozoa in the testes. This can result in a complete absence or significant reduction of sperm in the ejaculate.

According to various studies [1, 2], spermatogenic failure-62 (SPGF62) is characterized by male infertility due to nonobstructive azoospermia. The condition is often associated with impaired testicular function, leading to reduced production of testosterone and spermatozoa.

Some common features of SPGF62 include:

  • Azoospermia: complete absence of sperm in the ejaculate
  • Oligozoospermia: significantly reduced number of sperm in the ejaculate
  • Teratozoospermia: presence of abnormal or immature sperm in the ejaculate

The exact causes of SPGF62 are not yet fully understood, but it is believed to involve a combination of genetic and environmental factors [3]. Treatment options for SPGF62 typically focus on assisted reproductive technologies (ART) such as in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI), as the condition often requires external assistance to achieve pregnancy.

References:

[1] SC Esteves · 2018 · Cited by 16 — Spermatogenic failure has been recognized as the most severe presentation of male infertility in

Signs and Symptoms

Spermatogenic failure, also known as non-obstructive azoospermia, is a condition where the testes are unable to produce sperm. The signs and symptoms of spermatogenic failure can vary from person to person, but here are some common ones:

  • Azoospermia: This is the most obvious sign of spermatogenic failure, where there is no sperm present in the semen.
  • Low libido: Hormonal imbalance can lead to low sex drive or decreased interest in sex.
  • Hormonal imbalance: Spermatogenic failure can be caused by hormonal imbalances, leading to symptoms such as fatigue, weight gain, and mood changes.
  • Testicular atrophy: The testicles may shrink or become smaller due to the lack of sperm production.
  • Infertility: This is the most significant symptom of spermatogenic failure, where a man is unable to conceive a child with his partner.

According to [1], Spermatogenic failure, x-linked, 1, only Sertoli cells line the seminiferous tubules, which can lead to azoospermia. In some cases, there may be no other obvious signs or symptoms of spermatogenic failure.

In addition to these physical symptoms, spermatogenic failure can also have emotional and psychological effects on a person, such as:

  • Anxiety: The inability to conceive a child can cause significant stress and anxiety.
  • Depression: Spermatogenic failure can lead to feelings of sadness, hopelessness, and depression.

It's essential to note that these symptoms can vary from person to person, and not everyone with spermatogenic failure will experience all of them. If you suspect you or your partner may have spermatogenic failure, it's crucial to consult a healthcare professional for proper diagnosis and treatment.

References: [1] Spermatogenic failure, x-linked, 1 (ORPHA:276234)

Additional Symptoms

Diagnostic Tests

Diagnostic Tests for Spermatogenic Failure

Spermatogenic failure, also known as male infertility due to testicular dysfunction, can be diagnosed through various tests and examinations.

  • Testicular Biopsy: This is a surgical procedure where a sample of tissue from the testicle is removed and examined under a microscope. It helps determine the histological diagnosis of azoospermia (no sperm in the semen) and can also provide sperm for assisted reproductive technologies like IVF [1, 3].
  • Semen Analysis: A semen analysis is a lab test that examines the semen sample to check for sperm count, motility, morphology, and other parameters. If the results show a very low number of sperm or no sperm, further tests like testicular biopsy may be recommended [6, 9].
  • Genetic Testing: Genetic testing can help identify conditions such as Klinefelter's syndrome, which is a genetic condition that affects male fertility. In some cases, a surgery to obtain a testicular biopsy may be necessary to confirm the diagnosis [9, 13].

Other Diagnostic Tests

  • Azoospermia Diagnosis: Testicular biopsy can help diagnose azoospermia, which is a condition where there are no sperm in the semen.
  • Spermatogenic Failure Diagnosis: Spermatogenic failure can be diagnosed through testicular biopsy and genetic testing.

References

[1] Dec 28, 2022 — Testicular biopsy.​​ This test involves removing samples from the testicle with a needle. If the results of the testicular biopsy show that sperm ...

[3] Testicular biopsy is performed in order to determine the histological diagnosis of azoospermia and for the extraction of spermatozoa to be used in assisted ...

[6] If a semen test shows a very low number of sperm or no sperm, you may need a testicular biopsy. This test can be done with general or local anesthesia.

[9] Genetic testing can also elucidate conditions such as Klinefelter's syndrome. In some men, a surgery to obtain a testicular biopsy is necessary to confirm the ...

[13] The patient was then suspected of a defect of primary spermatogenic failure due to mutation in single genes.

Treatment

Treatment Options for Spermatogenic Failure

Spermatogenic failure, also known as nonobstructive azoospermia, is a condition where the testes are unable to produce sperm. While there is no cure for this condition, various drug treatments have been explored to help restore spermatogenesis.

  • Gonadotropin therapy: This treatment involves administering gonadotropins, which stimulate the production of testosterone and other hormones necessary for spermatogenesis. Studies have shown that gonadotropin therapy can be effective in inducing spermatogenesis in some men with hypogonadotropic hypogonadism (HH) [1][2].
  • Pulsatile GnRH: This treatment involves administering a synthetic form of gonadotropin-releasing hormone (GnRH) to stimulate the production of testosterone and other hormones necessary for spermatogenesis. Research has shown that pulsatile GnRH can be effective in inducing spermatogenesis in men with HH [1].
  • Clomiphene citrate: This medication is commonly used to treat infertility in women, but it has also been found to be effective in improving semen parameters in patients with hypogonadotropic hypogonadism. Clomiphene citrate works by stimulating the production of testosterone and other hormones necessary for spermatogenesis [8].
  • Tamoxifen: This medication is another estrogen-receptor modulator that has been found to be effective in improving semen parameters in patients with hypogonadotropic hypogonadism. Tamoxifen works by blocking the action of estrogen on the testes, which can help stimulate spermatogenesis [8].
  • Antitumor necrosis factor alpha medications: Research has shown that antitumor necrosis factor alpha medications such as infliximab or etanercept may actually improve sperm motility in some men with spermatogenic failure [10].

It's essential to note that these treatments are not always effective and may have varying degrees of success depending on the individual case. Additionally, these treatments should only be considered under the guidance of a qualified healthcare professional.

References: [1] R Ramasamy (2012) - Spermatogenesis may be restored in most HH men with gonadotropin replacement therapy. [2] R Ramasamy (2012) - This review focuses on the rationale and current evidence for hormonal and antioxidant therapy in medical treatment of male infertility, spermatogenic failure... [8] Nov 9, 2023 — Clomiphene citrate is effective in improving the semen parameters in patients with hypogonadotropic hypogonadism. [10] by D Velez · 2021 · Cited by 11 — Antitumor necrosis factor alpha medications such as infliximab or etanercept may actually improve sperm motility (10).

Recommended Medications

  • Clomiphene citrate
  • Gonadotropin therapy
  • Pulsatile GnRH
  • Antitumor necrosis factor alpha medications
  • tamoxifen
  • Tamoxifen

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of Spermatogenic Failure

Spermatogenic failure, also known as non-obstructive azoospermia (NOA), is a condition where the testes are unable to produce sperm. The differential diagnosis of spermatogenic failure involves identifying the underlying causes of this condition.

Causes of Spermatogenic Failure

  • Genetic anomalies: Genetic abnormalities, such as Klinefelter syndrome (47,XXY), can cause spermatogenic failure [12][13].
  • Hypogonadotropic hypogonadism: This is a condition where the pituitary gland does not produce enough hormones to stimulate sperm production [7].
  • Cryptorchidism: Undescended testes can lead to impaired spermatogenesis [7].
  • Delayed puberty: Delayed or incomplete puberty can result in spermatogenic failure [7].
  • Male pseudohermaphroditism: This is a rare condition where the individual has both male and female reproductive organs, leading to impaired spermatogenesis [7].

Other Causes

  • Iatrogenic causes: Certain medications or treatments can impair spermatogenesis, leading to spermatogenic failure [15].
  • Testicular biopsy: In some cases, testicular biopsy may be performed to determine the cause of spermatogenic failure [8].

Importance of Differential Diagnosis

Accurate differential diagnosis is crucial in determining the underlying cause of spermatogenic failure. This information can guide treatment decisions and improve outcomes for individuals with this condition.

References:

[7] by LF Pisani · 2008 · Cited by 90 [12] by SC Esteves · 2015 · Cited by 16 [13] by SC Esteves · 2018 · Cited by 16 [15] by F Tüttelmann · 2018 · Cited by 11

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_6852
owl#annotatedSource
t388814
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0112351
core#notation
DOID:0112351
oboInOwl#hasDbXref
MIM:619673
rdf-schema#label
spermatogenic failure 62
oboInOwl#hasExactSynonym
SPGF62
IAO_0000115
A spermatogenic failure that is characterized by male infertility due to nonobstructive azoospermia with complete metaphase arrest at the spermatocyte stage that has_material_basis_in homozygous or compound heterozygous mutation in the RNF212 gene on chromosome 4p16.3.
rdf-schema#subClassOf
t388500
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000148
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.